Cartesian Therapeutics
RNAC
RNAC
56 hedge funds and large institutions have $52.6M invested in Cartesian Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 1.56% → 1.66% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
70% less call options, than puts
Call options by funds: $9K | Put options by funds: $30K
Holders
56
Holding in Top 10
1
Calls
$9K
Puts
$30K
Top Buyers
| 1 | +$7.38M | |
| 2 | +$6.67M | |
| 3 | +$3.56M | |
| 4 |
O
OrbiMed
New York
|
+$3.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.93M |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$1.17M | |
| 3 | -$740K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$221K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$200K |